Rebuilding pipeline after recent clinical setbacks Lundbeck to acquire AbideTx for up to $400M httpow.lyWkLC30oEpgRÂ
Rebuilding pipeline after recent clinical setbacks, @Lundbeck to acquire @AbideTx for up to $400M: http://ow.ly/WkLC30oEpgR
More From BioPortfolio on "Rebuilding pipeline after recent clinical setbacks, @Lundbeck to acquire @AbideTx for up to $400M: http://ow.ly/WkLC30oEpgR "